Published in Cancer Weekly, April 10th, 2001
The Phase I study results from research at the University of Michigan Health System were presented March 27, 2001, by James D. Geiger, MD, UMHS assistant professor of surgery and the study's principal investigator, at the annual meeting of the American Association for Cancer Research.
The research suggests that dendritic cells spiked with cancer proteins from a pediatric patient's own tumor can generate an immune response to the cancer, and may spark stabilization or regression of metastatic, or spreading, cancers. One of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.